The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

Second biggest killer after lung cancer. WHO ... HOW MANY? 21,000. Second most common male cancer. SURVIVAL RATE: 50%. WHO? Men aged over 60. Half of sufferers are over 75. Risk factors: family ...

A new U.S. government study provides the most complete picture yet of early-onset cancers, defined as cancer diagnosed before ...

A new NIH-led study finds rising rates of 14 cancer types in Americans under 50, especially breast, colorectal, kidney, ...

Cindy was a healthy, 35-year-old woman with no symptoms of cancer when she joined the American Lung Association’s Lung Health ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to a preclinical study led by Roswell Park Comprehensive Cancer Center.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Recent studies have suggested that tattoos, chemical hair straighteners and even hot tea might be a problem. Here’s what an oncologist recommends.

The issue is that there aren’t any lung cancer tests that are completely free of risks. A low dose computed tomography (LDCT) imaging scan is the most common screening tool for people who aren ...

Opdivo (nivolumab) is a brand-name IV infusion prescribed for non-small cell lung cancer (NSCLC) in some situations. This article covers topics such as side effects, dosage, and how Opdivo works.

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered in a new study in mice and humans by researchers at UCL ...

Cells expressing the basal cell marker KRT5 have been fluorescently labelled and can be seen spreading throughout the bronchial tree The ‘cell of origin’ of the second most common lung cancer ...